Clinical trials
Shock clinical trials
Below are recruiting shock clinical trials, each written for real people, not researchers. We’re tracking 313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06809868Recruiting
Study of genetic elements in sepsis and aging
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
San Francisco, CaliforniaAges 18 years+ - NCT06454734Recruiting
Shock wave therapy for leg lymphedema
This trial tests if shock wave therapy can help reduce leg swelling caused by lymphedema. It is for people with moderate to severe swelling that has affected at least the knee to foot area for 6 months or longer.
BarcelonaAges 18 years+ - NCT04748796RecruitingPhase 3
Landiolol to prevent death in ventilated septic shock patients
This trial tests whether landiolol (a short-acting heart-rate–lowering medicine) can reduce deaths compared with standard care in people in septic shock who have a fast heart rate and strong heart pumping. It is meant for a very specific type of critically ill patient while they are on a breathing machine.
AmiensAges 18 years+ - NCT06102304Recruiting
Shock wave therapy for pinched nerve in neck
This study tests whether focused shock waves (sound waves) can improve muscle and nerve function in people with neck pain caused by a pinched nerve in the lower neck. The treatment is painless and non-invasive, and aims to reduce pain and improve arm function.
Giza, DokkiAges 36–46 - NCT07562932Recruiting
Norepinephrine vs dopamine for cardiogenic shock
This study compares two blood pressure support medicines (norepinephrine and dopamine) in adults with cardiogenic shock, a condition where the heart cannot pump enough blood. It aims to find which medicine works better for patients with this severe heart condition.
Gwangju, Jeollanam-doAges 19 years+ - NCT03313687Recruiting
Safety and outcomes of modern treatments for shock
This study looks at how safe and effective current treatments are for people who have cardiogenic shock, a serious condition when the heart cannot pump enough blood. It mainly aims to understand outcomes from treatment in a hospital setting, which may help improve care for future patients.
HamburgAges 18 years+ - NCT05415332Recruiting
Tracking outcomes for cardiogenic shock in ICU
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
SeoulAges 19 years+ - NCT05366452Recruiting
Early heart pump implant for shock after a heart attack
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
Marseille, Bouche DU RhoneAges 18–80 - NCT05752383Recruiting
Study of how cardiogenic shock patients do in the ICU
This study looks at what happens to people with cardiogenic shock while they are in the intensive care unit (ICU), including how their heart and blood circulation change over time. It may help doctors better understand the course of illness in this specific type of shock and improve care.
AmiensAges 18 years+ - NCT06145828Recruiting
Testing a blood filter for severe pneumonia or sepsis in AIDS patients
This study tests a technique that filters harmful substances from the blood of people with AIDS who have severe pneumonia or septic shock. The goal is to see if this filter helps them recover better.
Guangzhou, GuangdongAges 18–65 - NCT06078436Recruiting
Early carvedilol for heart failure shock
This trial tests whether starting the heart failure medication carvedilol early, along with standard monitoring, can help people in cardiogenic shock (when the heart can't pump enough blood) due to a weak heart muscle. It aims to see if earlier treatment improves outcomes.
SeoulAges 19 years+ - NCT04474106Recruiting
Shock wave therapy for new spinal cord injuries
This study tests whether extracorporeal shock wave therapy (non-surgical shock waves delivered from outside the body) can improve movement and sensation after a recent spinal cord injury. It may help people recover motor (movement) and sensory (feeling) function within months after injury.
Innsbruck, TyrolAges 18–99 - NCT07864948Recruiting
Shock wave therapy with or without taping for heel pain
This study tests two treatments for heel pain caused by plantar fasciitis. You'll get either shock wave therapy alone, or shock wave therapy plus special tape (kinesiotaping), to see which is better for reducing pain.
Ankara, ÇankayaAges 18–65 - NCT06369818Recruiting
Heart output measurement in shock patients on life support
This study tests if a new way of measuring heart function (using sound waves and breath analysis) works well in patients who are in severe heart failure and need a heart-lung machine. It might help doctors better monitor patients after heart surgery.
MünsterAges 18 years+ - NCT05850962Recruiting
Personalized blood pressure targets for ICU shock care
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
Newcastle, New South WalesAges 40 years+ - NCT07825363Recruiting
Early warning system for heart failure or heart attack patients
This study tests a sensor that monitors oxygen levels in body tissues to help doctors spot when your heart is not pumping enough blood early. The goal is to catch problems sooner so you can get faster treatment.
Weston, FloridaAges 18 years+ - NCT07807410Recruiting
Special dialysis filter for septic shock with kidney failure
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
Guangzhou, GuangdongAges 18 years+ - NCT07769528Recruiting
Heart pump support for severe heart failure
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07774962Recruiting
Comparing fingertip refill time and blood oxygen use in septic shock
This study looks at two ways to check blood flow and oxygen use in people with septic shock, a severe infection-related condition. It aims to see if a simple bedside test (fingertip refill) and a blood measure (oxygen extraction ratio) agree, which could help guide treatment.
IstanbulAges 18 years+ - NCT04513288Recruiting
Immunonutrition with L-citrulline for ICU sepsis patients
This trial tests whether adding L-citrulline to tube feeding (enteral nutrition) can improve outcomes for people in the ICU with sepsis or septic shock. It may help support the body’s immune response while you’re critically ill.
Rennes, Brittany RegionAges 18 years+ - NCT07716956Recruiting
Magnesium therapy for severe septic shock
This trial tests whether raising magnesium levels in the blood to a normal upper range can help reduce the need for strong blood pressure medications in people with severe septic shock. It might help stabilize blood pressure and improve recovery.
Alexandria, Alexandria GovernorateAges 18 years+ - NCT05586282Recruiting
Study proteins that may worsen fluid leaks in shock
This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.
ParisAges 18 years+ - NCT05990491Recruiting
Pituitary function after recovery from septic shock in ICU survivors
This study checks how well the pituitary gland (a small gland in your brain that controls hormones) works after you recover from a severe infection that caused dangerously low blood pressure (septic shock). It aims to see if the gland was affected during your ICU stay.
Lucknow, Uttar PradeshAges 18–80 - NCT07714746RecruitingPhase 3
Ivabradine for treating cardiogenic shock after heart attack
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
KarachiAges 18–75
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for shock?
- Yes. Clin2 currently lists 313 recruiting shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.